Standout Papers

Vitamin D Deficiency and Risk of Cardiovascular Disease 2003 2026 2010 2018 1.8k
  1. Vitamin D Deficiency and Risk of Cardiovascular Disease (2008)
    Thomas J. Wang, Michael J. Pencina et al. Circulation
  2. Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis (2008)
    Orlando M. Gutiérrez, Michael Mannstadt et al. New England Journal of Medicine
  3. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease (2011)
    Tamara Isakova, Patricia Wahl et al. Kidney International
  4. Fibroblast Growth Factor-23 Mitigates Hyperphosphatemia but Accentuates Calcitriol Deficiency in Chronic Kidney Disease (2005)
    Orlando M. Gutiérrez, Tamara Isakova et al. Journal of the American Society of Nephrology
  5. Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy (2003)
    Ming Teng, Myles Wolf et al. New England Journal of Medicine
  6. Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States (2007)
    David Martins, Myles Wolf et al. Archives of Internal Medicine
  7. Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease (2009)
    Orlando M. Gutiérrez, James L. Januzzi et al. Circulation
  8. Vitamin D levels and early mortality among incident hemodialysis patients (2007)
    Myles Wolf, Anand Shah et al. Kidney International
  9. Activated Injectable Vitamin D and Hemodialysis Survival (2005)
    Ming Teng, Myles Wolf et al. Journal of the American Society of Nephrology
  10. Effects of Phosphate Binders in Moderate CKD (2012)
    Geoffrey A. Block, David C. Wheeler et al. Journal of the American Society of Nephrology
  11. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production (2015)
    Valentin David, Aline Martin et al. Kidney International
  12. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia (2020)
    Myles Wolf, Janet Rubin et al. JAMA

Immediate Impact

9 from Science/Nature 88 standout
Sub-graph 1 of 19

Citing Papers

Ferric Carboxymaltose in Heart Failure with Iron Deficiency
2023 Standout
High-dimensional characterization of post-acute sequelae of COVID-19
2021 StandoutNature
1 intermediate paper

Works of Myles Wolf being referenced

Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia
2020 Standout
Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks
2017

Author Peers

Author Last Decade Papers Cites
Myles Wolf 13213 7497 5384 242 21.8k
Ravi Thadhani 8912 7602 3936 292 29.6k
Bryan Kestenbaum 8099 3656 2485 242 15.0k
Tilman B. Drüeke 10954 2441 3434 436 18.1k
Geoffrey A. Block 9186 2208 3323 158 14.5k
Michel Chonchol 5662 2932 1792 312 13.6k
Ziad A. Massy 11138 1382 2363 434 21.2k
Markus Ketteler 8218 1523 3136 238 12.9k
Mary B. Leonard 4329 2545 1591 276 14.5k
Ian R. Reid 2515 6573 3179 475 30.4k
Sharon M. Moe 10033 2620 2958 280 13.9k

All Works

Loading papers...

Rankless by CCL
2026